-
-
Call more information
660-596-2224 -
Author: Kaleigh Rogers FiveThirtyEight In a matter of weeks, face masks went from being considered unnecessary, and possibly harmful, to mandatory in many places across the U.S. You’re forgiven if you’ve got a bit of whiplash. Currently, the scientific consensus is that face masks are at least somewhat effective at preventing the spread of COVID-19, and both the World Health Organization and the Centers […]
Read MoreBy Heather Landi Fierce Healthcare AppliedVR says its recent study is the first one to look at the effectiveness of virtual reality therapy when self-administered at home by chronic pain patients. (AppliedVR) Los Angeles-based AppliedVR’s virtual reality platform—which uses goggles and headsets to create an immersive, 3D virtual world—has been aimed at alleviating everything from […]
Read MoreAuthor: Julie Steenhuysen Reuters Moderna Inc’s (MRNA.O) experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday. Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in […]
Read MoreAuthor: Michael Walter Cardiovascular Business COVID-19 is associated with a greater risk of acute ischemic stroke than more traditional viral respiratory infections, according to new findings published in JAMA Neurology. “Recent publications from China, France, and New York raise the possibility that COVID-19 might increase the risk of ischemic stroke,” wrote lead author Alexander E. Merkler, […]
Read MoreAuthor: Manas Mishra Reuters Gilead Sciences Inc (GILD.O) said on Monday it expects to be able to supply enough of its antiviral drug remdesivir by year end to treat more than 2 million COVID-19 patients, more than double its previous target of 1 million. The company also said it hoped to start trials in August […]
Read More